ARC Capital 参与澳大利亚 - 中国生物技术投资

ARC Capital 参与澳大利亚 – 中国生物技术投资

上周一,ARC Capital 参与了2017年澳中生物技术投资,这是寻找与来自世界各地具有领先技术的生物技术创新者合作机会的地方。

该会于3月27日星期一在上海万豪酒店举行。 该活动以公司演讲,主题演讲,活跃的小组讨论为特色,是我们与潜在客户会面的理想场所。

我们与以下公司洽谈合作:

  • Petri Exchange
  • Biotron
  • NOVOGEN
  • FivepHusion
  • ResApp

即将到来的合作伙伴关系表明ARC Capital有能力协助私人及上市公司。

Continue reading

Alarar Capital Group Securities Adds Underwriting License, Strengthening Global Capital Markets Platform

Alarar Capital Group Securities Adds Underwriting License, Strengthening Global Capital Markets Platform

Alarar Capital Group Securities LLC (“ARC Securities”), a wholly owned subsidiary of Alarar Capital Group, is pleased to announce that it has received approval from the Financial Industry Regulatory Authority (FINRA) to operate as a registered underwriting broker-dealer in the United States. This milestone marks a significant step in ARC Securities’ ongoing expansion of its global capital […]
Alarar Capital Group Appointed as Exclusive Financial Advisor to XRP Healthcare M&A Holding Inc. on Definitive Agreement for Proposed Qualifying Transaction with AAJ Capital 3 Corp.
Alarar Capital Group Joins Celebration of the Best Workplaces™ in Hong Kong 2025

Please complete this form to download the case study

This field is for validation purposes and should be left unchanged.
*Required before submission